Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Lowers Price Target to $13

Benzinga · 2d ago
Wells Fargo analyst Larry Biegelsen maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Weight and lowers the price target from $15 to $13.